Engineered Microalgae Promoting Angiogenesis for Diabetic Bone Regeneration
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.71460 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Zhaoyang Ran und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Orthopedic Implants, Department of Orthopedics, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine,…. Hauptthemen laut MEDLINE: Bone Regeneration, Microalgae, Neovascularization, Physiologic, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key Research & Development Program of China, National Natural Science Foundation of China, Shanghai Science and Technology Commission.
Abstract (Originalsprache)
Diabetic bone defects, characterized by hyperglycemia‐induced accumulation of advanced glycation end products (AGEs), oxidative stress, and an inflammatory microenvironment, face impaired angiogenesis, and compromised bone regeneration. This study demonstrates that palladium (Pd)‐engineered Spirulina platensis (SPP) effectively modulates the pathological diabetic bone microenvironment. Compared with native SP, SPP exhibits significantly enhanced capabilities: it reduces intracellular reactive oxygen species (ROS) and AGEs accumulation in endothelial cells, promotes pro‐inflammatory M1 macrophages toward the anti‐inflammatory M2 phenotype, and promotes the proliferation, migration, and tube formation of HUVECs under hyperglycemic conditions. Moreover, SPP treatment upregulates the HIF‐1α/VEGF signaling axis. To further validate its therapeutic potential, SPP was incorporated into a 3D‐bioprinted hydrogel scaffold (SPP@Gel), which accelerated the repair of critical‐sized cranial defects in diabetic rats by reducing AGEs accumulation and inflammatory marker expression in the defect area, promoting local angiogenesis. Overall, this study establishes the feasibility of using Pd nanoparticle engineering to potentiate the bioactivity of natural microalgae, offering an exploratory strategy for diabetic bone regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Key Laboratory of Orthopedic Implants, Department of Orthopedics, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Shanghai Engineering Research Center of Innovative Orthopaedic Instruments and Personalized Medicine, Clinical and Translational Research Center for 3D Printing Technology, Shanghai, China.
- School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, Shanxi, China.
- Key Laboratory of Inorganic Coating Materials, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai, China.
ORCID-Profile: Shasha Liu, Jingke Fu
Förderung
- National Key Research & Development Program of China
- National Natural Science Foundation of China
- Shanghai Science and Technology Commission
- Shanghai Municipal Commission of Economy and Informatization
Zitieren
APA
Ran, Z., Chen, T., Luo, D., Sun, L., Liu, S., Wang, X., Wang, Y., Deng, L., Zhu, Y., Hao, Y., & Fu, J. (2026). Engineered Microalgae Promoting Angiogenesis for Diabetic Bone Regeneration. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71460
Vancouver
Ran Z, Chen T, Luo D, Sun L, Liu S, Wang X, et al. Engineered Microalgae Promoting Angiogenesis for Diabetic Bone Regeneration. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71460
BibTeX
@article{Ran2026,
author = {Ran, Zhaoyang and Chen, Tinglong and Luo, Dinghao and Sun, Lin and Liu, Shasha and Wang, Xiaoqing and Wang, Yingnan and Deng, Liang and Zhu, Yingchun and Hao, Yongqiang and Fu, Jingke},
title = {Engineered Microalgae Promoting Angiogenesis for Diabetic Bone Regeneration},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71460}
}
EUVIMED